Ratings changes for Sunrun, RxSight, Bio-Techne, Microsoft, Wingstop, Tandem Diabetes Care, GeneDx and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Apple (NASDAQ:AAPL) had its “outperform” rating reaffirmed by Wedbush () (analyst Daniel Ives). They now have a $270.00 price target on the stock. This represents a 28.6% upside from the current price of $210.01.
insider Jeffrey P. Bezos sold 927,863 shares of Amazon.com stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $223.73, for a total value of $207,590,788.99. Following the sale, the insider owned 904,527,112 shares of the company’s stock, valued at approximately $202,369,850,767.76. The trade was a 0.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
insider Jeffrey P. Bezos sold 2,046,582 shares of Amazon.com stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $223.92, for a total value of $458,270,641.44. Following the sale, the insider owned 902,480,530 shares of the company’s stock, valued at approximately $202,083,440,277.60. The trade was a 0.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Meta Platforms (NASDAQ:META) had its price target raised by TD Cowen () (analyst John Blackledge) from $700.00 to $800.00. They now have a “buy” rating on the stock. This represents a 11.0% upside from the current price of $720.67.
BridgeBio Pharma (NASDAQ:BBIO) was upgraded by analysts at Oppenheimer Holdings, Inc. from a “market perform” rating to an “outperform” rating. They now have a $60.00 price target on the stock. This represents a 33.6% upside from the current price of $44.90.
Bloom Energy (NYSE:BE) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $33.00 price target on the stock, up previously from $18.00. This represents a 24.6% upside from the current price of $26.48.
Brown-Forman (NYSE:BF.B) was upgraded by analysts at Rothschild & Co Redburn from a “sell” rating to a “neutral” rating. They now have a $30.00 price target on the stock. This represents a 5.3% upside from the current price of $28.50.
Caterpillar (NYSE:CAT) was upgraded by analysts at Melius from a “hold” rating to a “buy” rating. They now have a $500.00 price target on the stock. This represents a 24.1% upside from the current price of $402.90.
Citizens Financial Group (NYSE:CFG) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $57.00 price target on the stock. This represents a 19.0% upside from the current price of $47.91.
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $200.00 price target on the stock, up previously from $150.00. This represents a 24.6% upside from the current price of $160.47.
Doximity (NASDAQ:DOCS) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $70.00 price target on the stock, up previously from $50.00. This represents a 9.4% upside from the current price of $63.97.
FOX (NASDAQ:FOXA) was upgraded by analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating.The current price is $55.22.
Haemonetics (NYSE:HAE) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $90.00 price target on the stock. This represents a 13.2% upside from the current price of $79.49.
Hologic (NASDAQ:HOLX) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $80.00 price target on the stock, up previously from $60.00. This represents a 22.4% upside from the current price of $65.36.
JPMorgan Chase & Co. (NYSE:JPM) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $327.00 price target on the stock. This represents a 15.0% upside from the current price of $284.35.
Morgan Stanley (NYSE:MS) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $160.00 price target on the stock, up previously from $127.00. This represents a 12.1% upside from the current price of $142.75.
Microsoft (NASDAQ:MSFT) was upgraded by analysts at Oppenheimer Holdings, Inc. from a “market perform” rating to an “outperform” rating. They now have a $600.00 price target on the stock. This represents a 19.0% upside from the current price of $504.36.
The PNC Financial Services Group (NYSE:PNC) was upgraded by analysts at Keefe, Bruyette & Woods from an “underperform” rating to a “market perform” rating. They now have a $212.00 price target on the stock, up previously from $185.00. This represents a 5.7% upside from the current price of $200.57.
Sunrun (NASDAQ:RUN) was upgraded by analysts at Jefferies Financial Group Inc. from an “underperform” rating to a “hold” rating. They now have a $11.00 price target on the stock, up previously from $5.00. This represents a 10.3% upside from the current price of $9.97.
J. M. Smucker (NYSE:SJM) was upgraded by analysts at BNP Paribas Exane from an “underperform” rating to an “outperform” rating. They now have a $120.00 price target on the stock. This represents a 15.0% upside from the current price of $104.36.
The Hanover Insurance Group (NYSE:THG) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $188.00 price target on the stock. This represents a 14.4% upside from the current price of $164.31.
Warner Music Group (NASDAQ:WMG) was upgraded by analysts at Bank of America Corporation from an “underperform” rating to a “neutral” rating. They now have a $33.00 price target on the stock, up previously from $28.00. This represents a 8.7% upside from the current price of $30.36.
EOG Resources (NYSE:EOG) was downgraded by analysts at Roth Capital from a “buy” rating to a “neutral” rating. They now have a $134.00 price target on the stock, down previously from $140.00. This represents a 9.3% upside from the current price of $122.62.
Ero Copper (NYSE:ERO) was downgraded by analysts at National Bank Financial from an “outperform” rating to a “sector perform” rating.The current price is $15.08.
Freeport-McMoRan (NYSE:FCX) was downgraded by analysts at Bank of America Corporation from a “buy” rating to a “neutral” rating. They now have a $56.00 price target on the stock. This represents a 21.1% upside from the current price of $46.24.
LPL Financial (NASDAQ:LPLA) was downgraded by analysts at Citigroup Inc. from a “neutral” rating to a “sell” rating. They now have a $80.00 price target on the stock. This represents a 78.9% downside from the current price of $379.47.
Monster Beverage (NASDAQ:MNST) was downgraded by analysts at Rothschild & Co Redburn from a “buy” rating to a “neutral” rating. They now have a $60.00 price target on the stock. This represents a 0.6% downside from the current price of $60.36.
Norfolk Southern (NYSE:NSC) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $288.00 price target on the stock, up previously from $259.00. This represents a 10.2% upside from the current price of $261.37.
RxSight (NASDAQ:RXST) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $9.00 price target on the stock, down previously from $25.00. This represents a 32.9% upside from the current price of $6.77.
RxSight (NASDAQ:RXST) was downgraded by analysts at Oppenheimer Holdings, Inc. from an “outperform” rating to a “market perform” rating.The current price is $6.77.
Truist Financial (NYSE:TFC) was downgraded by analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating. They now have a $48.00 price target on the stock. This represents a 4.9% upside from the current price of $45.76.
XPO (NYSE:XPO) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $140.00 price target on the stock, up previously from $137.00. This represents a 5.6% upside from the current price of $132.58.
[No Brainer Gold Play]: “Show me a better investment.” (ad)
A Historic Gold Announcement Is About to Rock Wall Street?
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Alamos Gold (NYSE:AGI) (TSE:AGI) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating on the stock.The current price is $26.02.
C3.ai (NYSE:AI) is now covered by analysts at Westpark Capital. They set a “buy” rating and a $40.00 price target on the stock. This represents a 46.6% upside from the current price of $27.28.
British American Tobacco (NYSE:BTI) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating on the stock.The current price is $48.93.
Coya Therapeutics (NASDAQ:COYA) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $16.00 price target on the stock. This represents a 158.7% upside from the current price of $6.19.
Ero Copper (NYSE:ERO) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating on the stock.The current price is $15.08.
Freeport-McMoRan (NYSE:FCX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $56.00 price target on the stock. This represents a 21.1% upside from the current price of $46.24.
Genius Sports (NYSE:GENI) is now covered by analysts at Arete. They set a “buy” rating and a $15.00 price target on the stock. This represents a 41.3% upside from the current price of $10.62.
Inovio Pharmaceuticals (NASDAQ:INO) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $5.00 price target on the stock. This represents a 263.6% upside from the current price of $1.38.
MongoDB (NASDAQ:MDB) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $280.00 price target on the stock. This represents a 31.3% upside from the current price of $213.20.
Altria Group (NYSE:MO) is now covered by analysts at Jefferies Financial Group Inc.. They set an “underperform” rating and a $50.00 price target on the stock. This represents a 14.0% downside from the current price of $58.16.
Newmont (NYSE:NEM) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $73.00 price target on the stock. This represents a 26.7% upside from the current price of $57.60.
Philip Morris International (NYSE:PM) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $220.00 price target on the stock. This represents a 24.6% upside from the current price of $176.63.
PROCEPT BioRobotics (NASDAQ:PRCT) is now covered by analysts at Stephens. They set an “overweight” rating and a $70.00 price target on the stock. This represents a 18.3% upside from the current price of $59.18.
LiveRamp (NYSE:RAMP) is now covered by analysts at DA Davidson. They set a “buy” rating and a $45.00 price target on the stock. This represents a 32.6% upside from the current price of $33.94.
Redwire (NYSE:RDW) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $20.00 price target on the stock. This represents a 26.4% upside from the current price of $15.82.
Cartesian Therapeutics (NASDAQ:RNAC) is now covered by analysts at Wedbush. They set an “outperform” rating and a $38.00 price target on the stock. This represents a 184.0% upside from the current price of $13.38.
Super Micro Computer (NASDAQ:SMCI) is now covered by analysts at Bank of America Corporation. They set an “underperform” rating and a $35.00 price target on the stock. This represents a 28.8% downside from the current price of $49.17.
Sportradar Group (NASDAQ:SRAD) is now covered by analysts at Arete. They set a “neutral” rating and a $31.00 price target on the stock. This represents a 6.2% upside from the current price of $29.19.
Starz Entertainment (NASDAQ:STRZ) is now covered by analysts at Benchmark Co.. They set a “buy” rating and a $39.00 price target on the stock. This represents a 146.8% upside from the current price of $15.80.
Bio-Techne (NASDAQ:TECH) is now covered by analysts at TD Cowen. They set a “buy” rating and a $65.00 price target on the stock. This represents a 22.6% upside from the current price of $53.02.
Teck Resources (NYSE:TECK) (TSE:TECK) is now covered by analysts at Stifel Nicolaus. They set a “hold” rating on the stock.The current price is $39.11.
GeneDx (NASDAQ:WGS) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $110.00 price target on the stock. This represents a 19.8% upside from the current price of $91.80.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.